ETHZ
Price
$1.84
Change
-$0.07 (-3.65%)
Updated
Oct 15, 11:16 AM (EDT)
Capitalization
308.34M
Intraday Buy/Sell Signals
PRQR
Price
$2.46
Change
+$0.17 (+7.42%)
Updated
Oct 14 closing price
Capitalization
258.09M
21 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

ETHZ vs PRQR

Header iconETHZ vs PRQR Comparison
Open Charts ETHZ vs PRQRBanner chart's image
ETHZilla
Price$1.84
Change-$0.07 (-3.65%)
Volume$3.02K
Capitalization308.34M
ProQR Therapeutics
Price$2.46
Change+$0.17 (+7.42%)
Volume$332.15K
Capitalization258.09M
ETHZ vs PRQR Comparison Chart in %
ETHZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRQR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ETHZ vs. PRQR commentary
Oct 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ETHZ is a Hold and PRQR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 16, 2025
Stock price -- (ETHZ: $1.92 vs. PRQR: $2.46)
Brand notoriety: ETHZ and PRQR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ETHZ: 43% vs. PRQR: 85%
Market capitalization -- ETHZ: $308.34M vs. PRQR: $258.09M
ETHZ [@Biotechnology] is valued at $308.34M. PRQR’s [@Biotechnology] market capitalization is $258.09M. The market cap for tickers in the [@Biotechnology] industry ranges from $105.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.07B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ETHZ’s FA Score shows that 0 FA rating(s) are green whilePRQR’s FA Score has 1 green FA rating(s).

  • ETHZ’s FA Score: 0 green, 5 red.
  • PRQR’s FA Score: 1 green, 4 red.
According to our system of comparison, PRQR is a better buy in the long-term than ETHZ.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ETHZ’s TA Score shows that 3 TA indicator(s) are bullish while PRQR’s TA Score has 6 bullish TA indicator(s).

  • ETHZ’s TA Score: 3 bullish, 4 bearish.
  • PRQR’s TA Score: 6 bullish, 5 bearish.
According to our system of comparison, PRQR is a better buy in the short-term than ETHZ.

Price Growth

ETHZ (@Biotechnology) experienced а -17.60% price change this week, while PRQR (@Biotechnology) price change was +8.37% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.76%. For the same industry, the average monthly price growth was +13.99%, and the average quarterly price growth was +268.92%.

Reported Earning Dates

PRQR is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+0.76% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ETHZ($308M) has a higher market cap than PRQR($258M). ETHZ YTD gains are higher at: 5.495 vs. PRQR (-7.170). ETHZ has higher annual earnings (EBITDA): -9.46M vs. PRQR (-35.56M). PRQR has more cash in the bank: 120M vs. ETHZ (2.22M). ETHZ has less debt than PRQR: ETHZ (1.41M) vs PRQR (16.9M). PRQR has higher revenues than ETHZ: PRQR (16.5M) vs ETHZ (0).
ETHZPRQRETHZ / PRQR
Capitalization308M258M119%
EBITDA-9.46M-35.56M27%
Gain YTD5.495-7.170-77%
P/E RatioN/AN/A-
Revenue016.5M-
Total Cash2.22M120M2%
Total Debt1.41M16.9M8%
FUNDAMENTALS RATINGS
ETHZ vs PRQR: Fundamental Ratings
ETHZ
PRQR
OUTLOOK RATING
1..100
6320
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
29
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
3545
P/E GROWTH RATING
1..100
97100
SEASONALITY SCORE
1..100
9050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PRQR's Valuation (29) in the Biotechnology industry is somewhat better than the same rating for ETHZ (85) in the Financial Conglomerates industry. This means that PRQR’s stock grew somewhat faster than ETHZ’s over the last 12 months.

PRQR's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ETHZ (100) in the Financial Conglomerates industry. This means that PRQR’s stock grew similarly to ETHZ’s over the last 12 months.

PRQR's SMR Rating (98) in the Biotechnology industry is in the same range as ETHZ (100) in the Financial Conglomerates industry. This means that PRQR’s stock grew similarly to ETHZ’s over the last 12 months.

ETHZ's Price Growth Rating (35) in the Financial Conglomerates industry is in the same range as PRQR (45) in the Biotechnology industry. This means that ETHZ’s stock grew similarly to PRQR’s over the last 12 months.

ETHZ's P/E Growth Rating (97) in the Financial Conglomerates industry is in the same range as PRQR (100) in the Biotechnology industry. This means that ETHZ’s stock grew similarly to PRQR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ETHZPRQR
RSI
ODDS (%)
N/A
Bearish Trend 10 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 8 days ago
86%
Bearish Trend 8 days ago
80%
Momentum
ODDS (%)
Bearish Trend 8 days ago
90%
Bullish Trend 8 days ago
88%
MACD
ODDS (%)
Bullish Trend 8 days ago
71%
Bullish Trend 8 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 8 days ago
90%
Bullish Trend 8 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 8 days ago
90%
Bullish Trend 8 days ago
83%
Advances
ODDS (%)
Bullish Trend 27 days ago
87%
Bullish Trend 13 days ago
85%
Declines
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 9 days ago
84%
BollingerBands
ODDS (%)
N/A
Bearish Trend 8 days ago
82%
Aroon
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 8 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
ETHZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRQR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TTFNF58.591.11
+1.93%
TotalEnergies SE
ATROB44.86N/A
N/A
Astronics Corp.
MLLCF3.50N/A
N/A
Molecular Partners AG
GEDC0.56N/A
N/A
CalEthos Inc.
KIKOF8.44N/A
N/A
Kikkoman Corp.

ETHZ and

Correlation & Price change

A.I.dvisor indicates that over the last year, ETHZ has been loosely correlated with HURA. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if ETHZ jumps, then HURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ETHZ
1D Price
Change %
ETHZ100%
-3.03%
HURA - ETHZ
56%
Loosely correlated
+4.12%
PRQR - ETHZ
45%
Loosely correlated
+7.42%
WVE - ETHZ
44%
Loosely correlated
+1.28%
KRRO - ETHZ
38%
Loosely correlated
+0.15%
PHMMF - ETHZ
33%
Poorly correlated
-9.49%
More

PRQR and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRQR has been closely correlated with WVE. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if PRQR jumps, then WVE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRQR
1D Price
Change %
PRQR100%
+7.42%
WVE - PRQR
67%
Closely correlated
+1.28%
KRRO - PRQR
56%
Loosely correlated
+0.15%
ETHZ - PRQR
45%
Loosely correlated
-3.03%
PHMMF - PRQR
36%
Loosely correlated
-9.49%
MGTX - PRQR
35%
Loosely correlated
+1.28%
More